Heat Seal Test for Pharmaceutical Blister Packaging: ISO 11607 and ASTM F88 Protocol
Pharmaceutical blister pack seal integrity is a patient safety issue. This guide covers the complete heat seal testing protocol — from equipment setup to acceptance criteria — per ISO 11607 and ASTM F88.
Why Blister Pack Seal Failure Is a Patient Safety Issue
A pharmaceutical blister pack is a sterile barrier system. Its seal is the last line of defense protecting drug product from moisture, oxygen, and microbial contamination. Seal failure — even microleaks below 250μm — compromises product sterility, stability, and efficacy. FDA and EMA have issued numerous warning letters and recall notices where insufficient seal integrity was identified as a root cause. For high-risk sterile products (injectable drug kits, biological products), seal integrity failure can be life-threatening.
Regulatory Framework: ISO 11607-1/-2, USP <1207>, and ASTM F88 for Sterile Packaging
ISO 11607-1 defines materials and sterile barrier system requirements. ISO 11607-2 defines validation requirements for forming, sealing, and assembly processes — including heat seal process qualification with defined acceptance criteria. USP <1207> classifies CCI methods in three tiers; ASTM F88 seal strength testing falls in the physical/chemical tier. The regulatory chain is: ISO 11607-2 requires process validation → USP <1207> specifies CCI testing → ASTM F88 provides the seal strength measurement method → ASTM F2029 standardizes the heat sealing procedure that makes F88-testable seals.
Step-by-Step ASTM F88 Test Procedure for Pharmaceutical Blister Seals
Step 1: Set heat seal tester to validated temperature/force/dwell parameters (use STH-3A gradient to determine these parameters during qualification). Step 2: Cut PVC/PVDC blister base and aluminum foil lidstock to specimen dimensions (typically 150mm × 25mm per ASTM F88). Step 3: Align specimen with sealant side to sealant side (film-to-film) or foil to base material. Step 4: Apply seal at validated parameters. Step 5: Condition 24 hours at 23°C ±2°C, 50% ±5% RH per ASTM F88 standard conditions. Step 6: Test peel strength at 180° angle using tensile tester at 250mm/min crosshead speed. Step 7: Report in N/15mm. Compare to acceptance criterion (typically ≥10N/15mm for blister lidstock).
Detecting Microleaks <250μm: Beyond Visual Inspection
ASTM F88 seal strength testing validates the process parameters that produce adequate seals. But it does not detect microleaks in individual production units. Microleak detection methods for pharmaceutical blister packs include: ASTM F1929 (dye penetration) for porous packages; helium leak detection for foil/foil systems; high-voltage leak detection (corona method); laser-headspace analysis for sealed cavities. USP <1207> recommends a tiered testing approach using F88 for process qualification and leak detection methods for batch release. KHT STH testers support the F88 process qualification step.
Interpreting Results: Pass/Fail Criteria and Minimum Seal Strength Values
Minimum acceptable seal strength for pharmaceutical blister packs is application-dependent and must be established by validation. Guidance values: PVC/PVDC-aluminum foil lidstock: ≥10N/15mm; flexible pharmaceutical pouches (Tyvek/PE): ≥20N/25mm; polyester/aluminum/polyethylene laminates: ≥25N/25mm. Acceptance criteria should be set with a safety margin above the minimum value that ensures process robustness — typically 1.3–1.5× the minimum. The STH-3A gradient model provides the temperature-seal strength curve data needed to define this margin.
Related Resources
Ready to Apply This in Your Lab?
Tell us your packaging material and testing standard — we'll recommend the right KHT STH model.
Get a Quote →Frequently Asked Questions
Questions About Heat Seal Testing?
Our engineers answer specification, compliance, and selection questions. Factory-direct pricing, 24-hour response.
Contact KHT Instrument